Alpha 2.0
Login Register
» Articles » PMID: 32561528

Doing Things Differently: What It Would Take to Ensure Continued Access to Contraception During COVID-19

Overview
Journal Glob Health Sci Pract
Specialty Public Health
Date 2020 Jun 21
PMID 32561528
Citations 23
Authors
Michelle Weinberger
Brendan Hayes
Julia White
John Skibiak
Affiliations
Soon will be listed here.
Citing Articles

Adaptations to comprehensive abortion care during the COVID-19 pandemic: case studies of provision in Bolivia, Mali, Nepal, and the occupied Palestinian territory.

Sorhaindo A, Castle S, Flomen L, Lathrop E, Mohagheghpour S, Dabash R Sex Reprod Health Matters. 2023; 31(1):2249694.

PMID: 37747711 PMC: 11003643. DOI: 10.1080/26410397.2023.2249694.

Contraceptive method switching and discontinuation during the COVID-19 pandemic in Myanmar: findings from a longitudinal cohort study.

Felker-Kantor E, Aung Y, Wheeler J, Keller B, Paudel M, Little K Sex Reprod Health Matters. 2023; 31(1):2215568.

PMID: 37335341 PMC: 10281389. DOI: 10.1080/26410397.2023.2215568.

The knock-on effects of COVID-19 pandemic on the supply and availability of generic medicines in Ethiopia: mixed methods study.

Mekonnen Z, Melaku T, Tucho G, Mecha M, Ardal C, Jahre M BMC Health Serv Res. 2023; 23(1):513.

PMID: 37210502 PMC: 10199739. DOI: 10.1186/s12913-023-09535-z.

Exploring the effects of COVID-19 on family planning: results from a qualitative study in rural Uganda following COVID-19 lockdown.

Sileo K, Muhumuza C, Helal T, Olfers A, Lule H, Sekamatte S Reprod Health. 2023; 20(1):31.

PMID: 36759838 PMC: 9910252. DOI: 10.1186/s12978-023-01566-3.

Trends of intrauterine device insertion and 'Googling' about intrauterine devices before and during the COVID-19 pandemic in Australia.

Darcy S, Cao C, Ahn S, Allan V, Ahmadvand A Digit Health. 2022; 8:20552076221145799.

PMID: 36583085 PMC: 9793017. DOI: 10.1177/20552076221145799.

References
1.
Nanda K, Lebetkin E, Steiner M, Yacobson I, Dorflinger L . Contraception in the Era of COVID-19. Glob Health Sci Pract. 2020; 8(2):166-168. PMC: 7326510. DOI: 10.9745/GHSP-D-20-00119. View
2.
Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S . Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016; 31(11):2491-2498. PMC: 5088635. DOI: 10.1093/humrep/dew222. View
3.
Riley T, Sully E, Ahmed Z, Biddlecom A . Estimates of the Potential Impact of the COVID-19 Pandemic on Sexual and Reproductive Health In Low- and Middle-Income Countries. Int Perspect Sex Reprod Health. 2020; 46:73-76. DOI: 10.1363/46e9020. View
4.
Remme M, Narasimhan M, Wilson D, Ali M, Vijayasingham L, Ghani F . Self care interventions for sexual and reproductive health and rights: costs, benefits, and financing. BMJ. 2019; 365:l1228. PMC: 6441864. DOI: 10.1136/bmj.l1228. View
5.
McNicholas C, Maddipati R, Zhao Q, Swor E, Peipert J . Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration. Obstet Gynecol. 2015; 125(3):599-604. PMC: 4347947. DOI: 10.1097/AOG.0000000000000690. View